Breaking News on Biopharmaceutical Development & Manufacturing


News headlines

Daiichi Sankyo pumping $135m into antibody-drug conjugate production

28-Apr-2017 - Daiichi Sankyo will plough ‎¥15bn ($135m) into three Japanese manufacturing facilities to support its antibody-drug conjugate pipeline.


Boehringer Ingelheim upping capacity with €700m mammalian cell culture plant

27-Apr-2017 - Boehringer Ingelheim has broken ground on a €700m stainless steel bioproduction facility set to house 135,000L of mammalian cell culture capacity.

United BioPharma selects GE Healthcare’s FlexFactory for Taiwan HIV drug plant

27-Apr-2017 - United BioPharma Inc. (UBP), with government backing, has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility in Hsinchu Industrial Park, Taiwan.

Thermo Fisher collaborates to establish single-use and automation site in China

27-Apr-2017 - Mab-Venture Biopharma has entered a collaboration to establish an antibody development and production plant in China incorporating Thermo Fisher’s single-use bioreactors and SmartFactory automated technology.


Getting a feel for biomanufacturing at the Biotech Training Facility

25-Apr-2017 - Hands-on teaching offers drugmakers, vendors and regulators a better understanding of bioprocessing, according to the managing director of a training facility in Leiden, The Netherlands.

Samsung Bioepis to take on J&J with FDA approved Remicade biosimilar

24-Apr-2017 - Samsung Bioepis’ Renflexis has become the second biosimilar of rheumatoid arthritis biologic Remicade (infliximab) to be recommended for approval in the US.

Cobra to boost gene therapy and CAR-T capacity through £15m investment

18-Apr-2017 - Cobra Biologics has said it will spend £15m ($19m) to increase gene therapy production capacity, citing customer demand and market opportunities.

Fujifilm invests $130m in CDMO business, ups mammlian bioreactor capacity 70%

18-Apr-2017 - Fujifilm has invested around $130m into facilities in the US and UK weeks after launching its biopharma CDMO business.

Speed, yield and quality critical for cell line development, says ATUM

12-Apr-2017 - ATUM has launched itself into the mammalian cell line development space after being awarded patents for its Leap-In transposase genome technology.

Dispatches from the 1st Stem Cell Community Day, Hamburg

UK Catapult: QbD and process automation key for making commercial cell therapies

05-Apr-2017 - Process automation should be incorporated early when developing large scale cell therapy manufacturing platforms, according to a lead scientist from the UK Catapult.

Stem cell community meets in Hamburg

04-Apr-2017 - is at @Eppendorf_AG 's stem cell community day in Hamburg, Germany. Here is a collection of tweets sent from the conference.

CBMG completes Wuxi stem cell plant expansion

04-Apr-2017 - Cellular Biomedicine Group Inc (CBMG) has expanded its stem cell manufacturing facility in Huishan High Tech Park in Wuxi, China.

Agenus trimming 50 jobs as it focuses on cancer vaccines and antibodies

31-Mar-2017 - Immuno-oncology antibody and vaccine firm Agenus Inc will close a site in Basel and axe 50 jobs as part of a reorganisation.

Lonza confirms drug firm was biggest customer in 2016

31-Mar-2017 - Lonza's biopharma business grew faster than other divisions in 2016 with a drug firm becoming the Swiss life science supplier's biggest customer for the first time since 2013

Regeneron and Sanofi's $37,000 per year eczema mAb given US FDA nod

29-Mar-2017 - The US FDA has approved the first systematic treatment for eczema: Sanofi and Regeneron’ monoclonal antibody Dupixent (dupilumab).

Lilly: Tax reforms would release $150m to further support US manufacturing

27-Mar-2017 - Eli Lilly will invest $850m in its US operations this year but warns the country’s antiquated tax system leaves the firm at a competitive disadvantage.

Caladrius: 'Hitachi will unlock full potential of cell therapy CDMO PCT'

24-Mar-2017 - Hitachi Chemical Co. America will increase its presence in the cell therapy development and manufacturing space through the $75m acquisition of Caladrius Biosciences subsidiary PCT.

Eurofins pumping $5m into a UK biopharmaceutical testing site

24-Mar-2017 - Eurofins will expand its UK biopharmaceutical testing offering through a £4m ($5m) facility in Livingston, Scotland.

GSK breaks ground on $175m German Bexsero vaccine facility

21-Mar-2017 - GlaxoSmithKline has broken ground on a €162m ($175m) meningococcal B vaccine production plant in Germany.

EC says separate GMP for cell and gene therapies is necessary

21-Mar-2017 - The European Commission has rejected PIC/S criticism of a plan to develop GMP for advanced therapies and stressed that separate rules will not mean a lowering of standards.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...

Product Innovation